Obesity and Metabolic Diseases Treatment | Amneal and Metsera Strategic Collaboration | Pharma News
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic…
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic…
Alkem Laboratories denies claims of Pan-D, Clavam 625 batches being not-of-standard quality The samples of both products mentioned…
Amneal Pharmaceuticals, Inc. announced that it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food…
BioMatrix Healthcare Pvt. Ltd announced that OSD facility has received EUGMP approval!This achievement is a testament to unwavering…